The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

Moffitt Cancer Center: Why we are building the first machine learning department in oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Imagine a future where cancer patients are able to receive the treatment they precisely need and not the treatment that is prescribed to all.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Issam El Naqa, PhD
Chair, Department of Machine Learning, Moffitt Cancer Center
Dana Rollison, PhD
Vice president, chief data officer, associate center director of data science, Division chief, quantitative science, Moffitt Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
By Rodney Haring
Byline
Issam El Naqa, PhD
Chair, Department of Machine Learning, Moffitt Cancer Center
Dana Rollison, PhD
Vice president, chief data officer, associate center director of data science, Division chief, quantitative science, Moffitt Cancer Center
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account